{"nctId":"NCT02189629","briefTitle":"CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris","startDateStruct":{"date":"2015-02-23","type":"ACTUAL"},"conditions":["Acne Vulgaris"],"count":453,"armGroups":[{"label":"CD5789 (trifarotene) cream","type":"EXPERIMENTAL","interventionNames":["Drug: CD5789 (trifarotene)"]}],"interventions":[{"name":"CD5789 (trifarotene)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The Subject has a facial acne severity grade of IGA grade 3 (moderate) at Screening and Baseline visits.\n* The Subject has a minimum of 20 inflammatory lesions and 25 non-inflammatory lesions at Screening and Baseline visits on the face.\n* Exclusion Criteria:\n* The subject has severe forms of acne (acne conglobata, acne fulminans) or secondary acne form (chloracne, drug-induced acne, etc.).\n* The Subject has more than 1 nodule on the face at Screening and at Baseline visits.\n* The Subject has any acne cyst on the face at Screening and at Baseline visits.","healthyVolunteers":false,"sex":"ALL","minimumAge":"9 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Investigator Global Assessment (IGA) Success Rate up to Week 52","description":"Number of subjects who achieved an Investigator Global Assessment (IGA) score of 1 (almost clear) or 0 (clear).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"453","spread":null}]}]}]},{"type":"SECONDARY","title":"Physician Global Assessment (PGA) Success Rate up to Week 52","description":"Number of subjects who achieved a Physician Global Assessment (PGA) score of 1 (almost clear) or 0 (clear).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"453","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10,"n":453},"commonTop":["Nasopharyngitis","Sunburn","Application Site Pruritis","Application Site Irritation","Upper Respiratory Tract Infection"]}}}